NASDAQ:AMTX Aemetis (AMTX) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free AMTX Stock Alerts $3.92 +0.02 (+0.51%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$3.88▼$4.1250-Day Range$2.89▼$6.0252-Week Range$1.16▼$8.99Volume1.03 million shsAverage Volume1.15 million shsMarket Capitalization$167.03 millionP/E RatioN/ADividend YieldN/APrice Target$10.30 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Aemetis alerts: Email Address Aemetis MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside162.8% Upside$10.30 Price TargetShort InterestBearish12.49% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.71Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.60) to ($0.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.30 out of 5 starsOils/Energy Sector197th out of 233 stocksIndustrial Organic Chemicals Industry16th out of 19 stocks 3.4 Analyst's Opinion Consensus RatingAemetis has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAemetis has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted12.49% of the outstanding shares of Aemetis have been sold short.Short Interest Ratio / Days to CoverAemetis has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in Aemetis has recently increased by 14.66%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAemetis does not currently pay a dividend.Dividend GrowthAemetis does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AMTX. Previous Next 2.6 News and Social Media Coverage News SentimentAemetis has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Aemetis this week, compared to 2 articles on an average week.Search InterestOnly 13 people have searched for AMTX on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Aemetis to their MarketBeat watchlist in the last 30 days. This is a decrease of -83% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aemetis insiders have not sold or bought any company stock.Percentage Held by Insiders16.44% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 27.02% of the stock of Aemetis is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aemetis are expected to grow in the coming year, from ($1.60) to ($0.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aemetis is -2.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aemetis is -2.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Aemetis Stock (NASDAQ:AMTX)Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies USP alcohol and hand sanitizer; and produces renewable natural gas, as well as distilled biodiesel from various vegetable oil and animal waste feedstocks. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies. Aemetis, Inc. is headquartered in Cupertino, California.Read More AMTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMTX Stock News HeadlinesApril 23, 2024 | finance.yahoo.comAemetis to Present to Institutional Investors at UBS, JP Morgan and Stifel Conferences to Review Recent Federal Approval of $200 Million of EB-5 Funding for SAF, Biogas, and CCS ProjectsApril 23, 2024 | americanbankingnews.comAemetis (NASDAQ:AMTX) Stock Passes Below 200 Day Moving Average of $4.33April 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 18, 2024 | markets.businessinsider.comPiper Sandler Keeps Their Sell Rating on Aemetis (AMTX)April 18, 2024 | investorplace.com7 Penny Growth Stocks to Buy ASAP Before They Go ParabolicApril 9, 2024 | msn.comAemetis awarded $10.5M in federal tax credits for biofuels projectsApril 9, 2024 | finance.yahoo.comAemetis Allocated $10.5 Million IRA Section 48C Tax Credits by DOE and IRS for Biofuels Plant Efficiency ProjectsApril 4, 2024 | markets.businessinsider.comBuy Rating Affirmed: Aemetis’s Growth and Prospects Outweigh RisksApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 1, 2024 | finance.yahoo.comAemetis Implements Microsoft Dynamics(TM) ERP System to Support Current Operations and Expansion ProjectsApril 1, 2024 | globenewswire.comAemetis Implements Microsoft Dynamics(TM) ERP System to Support Current Operations and Expansion ProjectsMarch 23, 2024 | wsj.comAemetis Inc.March 22, 2024 | msn.comAemetis (NASDAQ:AMTX) is a Prime ESG Investment OpportunityMarch 22, 2024 | seekingalpha.comAemetis CEO Interview - A Biofuel Company With 10x+ UpsideMarch 21, 2024 | marketwatch.comAemetis Shares Rise on Approval for $200 Million EB-5 ProgramMarch 21, 2024 | msn.comAemetis surges after USCIS approves $200M for renewable energy projectsMarch 21, 2024 | finance.yahoo.comAemetis Approved by USCIS for $200 million of EB-5 Investment in Biogas, SAF and Carbon Sequestration ProjectsMarch 20, 2024 | finance.yahoo.comAMTX Jan 2025 7.500 putMarch 20, 2024 | finance.yahoo.comAMTX May 2024 3.500 callMarch 16, 2024 | ca.finance.yahoo.comAMTX Apr 2024 3.500 putMarch 14, 2024 | finance.yahoo.comAMTX Mar 2024 3.000 putMarch 14, 2024 | finance.yahoo.comWhen Will Aemetis, Inc. (NASDAQ:AMTX) Breakeven?March 11, 2024 | finance.yahoo.comAMTX Jul 2024 10.000 putMarch 9, 2024 | seekingalpha.comAemetis, Inc. (AMTX) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | markets.businessinsider.comAemetis: Poised for Growth with Sustainable Fuels and Strong Performance – Buy Rating AffirmedMarch 8, 2024 | finance.yahoo.comAemetis, Inc. (NASDAQ:AMTX) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | finanznachrichten.deAemetis, Inc.: Aemetis Reports 2023 Fourth Quarter and Year-End ResultsSee More Headlines Receive AMTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/07/2024Today4/24/2024Next Earnings (Estimated)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorOils/Energy Industry Industrial organic chemicals Sub-IndustryN/A Current SymbolNASDAQ:AMTX CUSIPN/A CIK738214 Webwww.aemetis.com Phone(408) 213-0940Fax408-252-8044Employees205Year FoundedN/APrice Target and Rating Average Stock Price Target$10.30 High Stock Price Target$28.00 Low Stock Price Target$3.00 Potential Upside/Downside+162.8%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-46,420,000.00 Net Margins-24.86% Pretax Margin-53.64% Return on EquityN/A Return on Assets-43.11% Debt Debt-to-Equity RatioN/A Current Ratio0.43 Quick Ratio0.21 Sales & Book Value Annual Sales$186.72 million Price / Sales0.89 Cash FlowN/A Price / Cash FlowN/A Book Value($5.49) per share Price / Book-0.71Miscellaneous Outstanding Shares42,610,000Free Float35,604,000Market Cap$167.03 million OptionableOptionable Beta1.01 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Eric A. McAfee (Age 61)Co-Founder, Executive Chairman & CEO Comp: $460kMr. Todd A. Waltz (Age 63)Executive VP & CFO Comp: $371kMr. Andrew B. Foster (Age 59)Executive VP & COO Comp: $361.94kMr. Sanjeev Gupta (Age 64)Executive Vice President of Aemetis International Comp: $376.25kMr. J. Michael RockettExecutive VP, General Counsel & Corporate SecretaryKey CompetitorsGevoNASDAQ:GEVOVerde Clean FuelsNASDAQ:VGASOrigin MaterialsNASDAQ:ORGNFutureFuelNYSE:FFHallador EnergyNASDAQ:HNRGView All CompetitorsInsiders & InstitutionsCannell Capital LLCSold 150,000 shares on 2/15/2024Ownership: 0.000%National Bank of Canada FISold 3,275 shares on 2/6/2024Ownership: 0.000%Naomi Louise BonessSold 15,000 sharesTotal: $84,750.00 ($5.65/share)John R BlockSold 19,205 sharesTotal: $120,991.50 ($6.30/share)View All Insider TransactionsView All Institutional Transactions AMTX Stock Analysis - Frequently Asked Questions Should I buy or sell Aemetis stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AMTX shares. View AMTX analyst ratings or view top-rated stocks. What is Aemetis' stock price target for 2024? 4 brokers have issued 1 year target prices for Aemetis' stock. Their AMTX share price targets range from $3.00 to $28.00. On average, they predict the company's stock price to reach $10.30 in the next twelve months. This suggests a possible upside of 162.8% from the stock's current price. View analysts price targets for AMTX or view top-rated stocks among Wall Street analysts. How have AMTX shares performed in 2024? Aemetis' stock was trading at $5.24 at the beginning of 2024. Since then, AMTX stock has decreased by 25.2% and is now trading at $3.92. View the best growth stocks for 2024 here. Are investors shorting Aemetis? Aemetis saw a increase in short interest in March. As of March 31st, there was short interest totaling 5,320,000 shares, an increase of 14.7% from the March 15th total of 4,640,000 shares. Based on an average daily volume of 1,220,000 shares, the days-to-cover ratio is presently 4.4 days. View Aemetis' Short Interest. When is Aemetis' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our AMTX earnings forecast. How were Aemetis' earnings last quarter? Aemetis, Inc. (NASDAQ:AMTX) posted its quarterly earnings data on Thursday, March, 7th. The specialty chemicals company reported ($0.34) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.35) by $0.01. The specialty chemicals company had revenue of $70.76 million for the quarter, compared to the consensus estimate of $80.08 million. During the same period last year, the business earned ($0.63) EPS. What other stocks do shareholders of Aemetis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aemetis investors own include Pennsylvania Real Estate Investment Trust (PEI), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Tilly's (TLYS), Auxly Cannabis Group (CBWTF), Novan (NOVN), Aeterna Zentaris (AEZS), American Cannabis (AMMJ) and Bionano Genomics (BNGO). How do I buy shares of Aemetis? Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AMTX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aemetis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
